Saturday 17 October 2026
Export OMCL’s income statement to Excel — free account
Omnicell, Inc.
OMCL Healthcare Health Information Services
Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.
35.39
0.56
−1.56%
Follow OMCL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 6 | 8 | 8 |
| 1.62% | 0.17% | 1.63% | 3.06% | ||
| 0.94% | 0.10% | 0.98% | 1.89% | ||
ROIC |
0.89% | 0.27% | 1.77% | 3.10% | |
Return on Tangible Assets |
6.17% | 0.63% | 5.66% | 9.53% | |
Average Days of Receivables |
76.15 | 66.80 | 74.43 | 66.47 | |
Free Cash Flow per Share |
2.06 | 1.51 | 2.16 | 2.78 | |
Free Cash Flow |
93.75 | 69.37 | 97.82 | 126.77 | |
Capital Expenditures |
(59.51) | (57.93) | (58.06) | (54.67) | |
| Other line items | |||||
Cash ROIC |
5.98% | 4.35% | 5.88% | 7.24% | |
Accounts Receivable Turnover |
4.73 | 5.01 | 4.89 | 5.42 | |
Accounts Payable Turnover |
12.02 | 14.23 | 12.40 | 12.27 | |
Inventory Turnover |
6.55 | 7.19 | 7.27 | 6.80 | |
Average Days of Payables |
34.41 | 23.56 | 30.77 | 26.39 | |
Days of Inventory on Hand |
59.16 | 54.05 | 52.31 | 51.27 | |
Tax Rate |
(0.42) | (0.82) | (0.46) | (0.36) | |
Research and Development Expense of Revenue |
7.83% | 7.48% | 7.32% | 7.09% | |
Selling, General and Administrative Expense of Revenue |
34.44% | 34.57% | 33.43% | 33.03% | |
Share Based Compensation of Revenue |
3.53% | 3.76% | 3.53% | 3.60% | |
Interest Coverage |
— | — | — | 7.69 | |
Operating CF/Net income |
7.69 | 62.04 | 7.63 | 4.64 | |
Depreciation/Fixed assets |
0.75 | 0.74 | 0.72 | 0.71 | |
Capex/Depreciation |
(0.66) | (0.65) | (0.66) | (0.63) | |
Revenue per Share |
25.86 | 25.78 | 27.03 | 27.33 | |
Operating CF per Share |
3.37 | 2.77 | 3.44 | 3.98 | |
Capex per Share |
(1.31) | (1.26) | (1.28) | (1.20) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 |
Columns are period end dates